{"id":"W3042751537","doi":"10.1016/j.ahj.2020.07.008","title":"Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design","year":2020,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Janssen Pharmaceuticals; Principia Biopharma; Sanofi Genzyme; Bausch Health; Intercept Pharmaceuticals; AstraZeneca; Amarin Corporation; Novo Nordisk; Asahi Group Holdings; Medicines Company; Intarcia Therapeutics; Regeneron Pharmaceuticals; Mylan; Ionis Pharmaceuticals; Boston Scientific Corporation; Abbott Vascular; Duke Clinical Research Institute; MannKind Corporation; European Commission; Kowa Company; Sanofi; GlaxoSmithKline; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Semaglutide; Medicine; Overweight; Weight loss; Diabetes mellitus; Obesity; Adverse effect; Internal medicine; Population; Disease; Placebo; Type 2 diabetes; Intensive care medicine; Endocrinology; Liraglutide","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001771303,0.0001350357,0.0005252597,0.0000810422,0.00007048273,0.00002901529,0.00003150991,0.00001343865,0.00003085389],"category_scores_gemma":[0.0001092474,0.00008329077,0.0001007156,0.0002646659,0.00004236159,0.00005513357,0.00001689517,0.0001618352,0.00001645274],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007662368,"about_ca_system_score_gemma":0.00009048382,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004961394,"about_ca_topic_score_gemma":0.00001995388,"domain_scores_codex":[0.9990339,0.00012124,0.0001295718,0.0001824446,0.0003247902,0.0002081054],"domain_scores_gemma":[0.9993674,0.0002436492,0.00004455481,0.0001111084,0.00002874524,0.0002045766],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000597576,0.0002029181,0.9857485,0.00005749674,0.0009202267,0.0005202657,0.0004192776,0.0002093103,0.0001829741,0.00001613194,0.002978642,0.008146736],"study_design_scores_gemma":[0.002784498,0.004974534,0.983283,0.00009210072,0.0003411278,0.0001439069,0.0001523683,0.0002059042,0.001104786,0.000009617321,0.006766961,0.0001411277],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930966,0.0002844292,0.0007089686,0.00512052,0.00002461044,0.0005898521,8.259035e-7,0.00002293416,0.0001512098],"genre_scores_gemma":[0.9903025,0.0001353833,0.004786938,0.004429265,0.000106351,0.00002411471,0.000001911119,0.00001695871,0.0001966016],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008005609,"threshold_uncertainty_score":0.3396499,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01636962010853827,"score_gpt":0.2445446049952341,"score_spread":0.2281749848866959,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}